本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Nurix Therapeutics

25.44
-0.0600-0.24%
盤後25.440.00000.00%17:29 EDT
成交量:283.95萬
成交額:7,207.57萬
市值:26.31億
市盈率:-7.46
高:25.80
開:25.32
低:25.01
收:25.50
52周最高:28.23
52周最低:8.20
股本:1.03億
流通股本:9,504.52萬
量比:2.13
換手率:2.99%
股息:- -
股息率:- -
每股收益(TTM):-3.4102
每股收益(LYR):-3.0514
淨資產收益率:-80.30%
總資產收益率:-40.06%
市淨率:6.53
市盈率(LYR):-8.34

資料載入中...

2025/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/28

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/01/28

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

重要事件披露

Form 8-K - Current report
2024/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/31

重要事件披露

Form 8-K - Current report
2024/10/31

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/10/16

重要事件披露

Form 8-K - Current report
2024/10/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/11

重要事件披露

Form 8-K - Current report